Mortality and morbidity attributable to use of addictive substances in the United States
about
Trends in Current Tobacco Use, Smoking Rates and Quit Attempts among Saudi Population during Periods of 17 Years (1996-2012): Narrative Review ArticleCorticostriatal BDNF and alcohol addictionEthanol-BDNF interactions: still more questions than answers.Predictors of smoking among primary and secondary school students in BotswanaA point mutation in the ectodomain-transmembrane 2 interface eliminates the inhibitory effects of ethanol in P2X4 receptors.The relative efficacy of pamphlets, CD-ROM, and the Internet for disseminating adolescent drug abuse prevention programs: an exploratory study.Relationship of reasons and fears of treatment with outcome in substance using population attending a de-addiction centre.Knowledge, attitude and practice of tobacco smoking by medical students in Riyadh, Saudi ArabiaAlcohol and tobacco use patterns among heterosexually and homosexually experienced California women.Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patientsTobacco use and nicotine dependence among HIV-infected and uninfected injection drug users.Functional disability in late-middle-aged and older adults admitted to a safety-net hospitalPredictors of quit attempts among smokers enrolled in substance abuse treatment.Individual differences in initial sensitivity and acute tolerance predict patterns of chronic drug tolerance to nitrous-oxide-induced hypothermia in rats.Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months laterHeavy episodic drinking in early adulthood and outcomes in midlife.α4-Containing GABA(A) Receptors are Required for Antagonism of Ethanol-Induced Motor Incoordination and Hypnosis by the Imidazobenzodiazepine Ro15-4513.Antioxidant therapy attenuates deficient bone fracture repair associated with binge alcohol exposure.Impact of a brief training on medical resident screening for alcohol misuse and illicit drug use.Lifetime income patterns and alcohol consumption: investigating the association between long- and short-term income trajectories and drinking.Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disordersPerspectives in Implementing a Primary Care-Based Intervention to Reduce Alcohol MisuseThe effect of job stress on smoking and alcohol consumption.Challenges in understanding disparities in drug use and its consequencesThe health impact of childhood trauma: an interdisciplinary review, 1997-2003.Effect of nicotine on body composition in mice.Hospitalization-Associated Disability in Adults Admitted to a Safety-Net Hospital.Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London.Decreased injecting is associated with increased alcohol consumption among injecting drug users in northern Vietnam.Increased presynaptic regulation of dopamine neurotransmission in the nucleus accumbens core following chronic ethanol self-administration in female macaquesAdoption of medications in substance abuse treatment: priorities and strategies of single state authoritiesNursing care of children after a traumatic incident.Associations between body mass index and substance use disorders differ by gender: results from the National Epidemiologic Survey on Alcohol and Related Conditions.The Addiction Psychiatrist as Dual Diagnosis Physician: A Profession in Great Need and Greatly NeededIdentification of novel bone-specific molecular targets of binge alcohol and ibandronate by transcriptome analysis.Loop 2 structure in glycine and GABA(A) receptors plays a key role in determining ethanol sensitivity.Do adolescent drug use consequences predict externalizing and internalizing problems in emerging adulthood as well as traditional drug use measures in a Hispanic sample?Co-occurring substance-related and behavioral addiction problems: A person-centered, lay epidemiology approachIntramuscular extended-release naltrexone: current evidence.Combining medically assisted treatment and Twelve-Step programming: a perspective and review.
P2860
Q27021226-BD71838C-54A9-4644-AEA3-92346F27D34BQ28083756-1089BD3E-71BA-43F5-B2C6-4A5846BC157DQ30490427-A58F467C-A889-43CB-AD9B-FD044354DD35Q33570547-495D9249-678E-4988-9F01-D82732759445Q33601789-741B0C7E-D13A-4EF2-A105-1EA752B65038Q33720678-A8751A96-F954-4EB2-BDC7-F3E8A684753BQ33859534-DACF3831-CAA5-45C3-AA2D-1EBC107E7616Q34094210-D563B22A-69BC-4B4D-9298-0F4FA7310503Q34240324-5CFE7542-2352-4792-B303-0B6562CF735EQ34291872-442AF60C-259F-418F-B94A-6190902A0B7BQ34311573-31E3A8CF-702E-442B-817F-718B070FBEA6Q34559769-088FBD03-BBE7-480F-A3BC-E72B2160A709Q34602413-BC438019-0662-49F0-966D-E42D153E4DF6Q34644824-4A0D4056-CB0A-40A8-99DF-E3CD500A076CQ34859268-F813F089-5E07-4D73-80D4-76AEB63A71BEQ34884120-5AB91DBF-F741-4CC3-A002-1B55F64880CBQ35094727-65E70036-C476-4FBC-8818-7D5459DFBB2CQ35116013-5549B415-52CE-4D1D-8D90-EA58AE2FDF40Q35135407-07FF1A1D-F153-4665-B58A-0A38E76B1F63Q35256600-0957F755-C48D-4754-9EA7-110CE5DA34AAQ35527075-C882175B-7879-46F9-8F6A-512DF2B4441DQ35994599-EC1E2592-E0FD-4553-999D-1CFE46F7159DQ36111369-8A8B5522-482E-4DD0-9239-A01A04FAC560Q36149362-8C1B39DC-9152-4E6A-99FE-E4FD860C7E50Q36188377-18699E1E-9B05-40AD-B348-EED1B8C3266BQ36239552-31962503-ABC2-4FBB-92F5-49F0F6690854Q36258487-78E52BB7-D02C-4D2E-ACF7-CE72D11E5C4EQ36273602-09275674-9E3E-4113-9B0F-95C81AB784C3Q36639092-0E096DFF-D176-4B95-BB89-39B6879BBA80Q36746525-614B2383-413A-4B46-8BF2-0B30FB8481C7Q36806539-C5CACA46-A246-4B9D-8A03-A6A05763E2A6Q36871165-D0345AE7-A5AB-469A-B762-0A631CC87EC1Q37104565-6B0B12D2-221E-43BC-82E7-5CE561069E5FQ37284175-A058E314-664E-4DA5-9EB0-293028FEFBE2Q37309830-1B04ACFA-A2E9-4481-BB63-36157EAE3906Q37447989-CE118E03-FA84-4DE1-9FEA-4AB2409D8EC8Q37641649-C0058044-BB94-45F4-A420-1E72CE5ED8AFQ37726060-1DABFC2F-DCB7-4570-9843-2463030F90E8Q37832752-EE3DE487-4A2F-4185-99AD-496F0959921BQ39226314-18EC887D-4271-43E3-A60C-D49F7284E362
P2860
Mortality and morbidity attributable to use of addictive substances in the United States
description
1999 nî lūn-bûn
@nan
1999 թուականին հրատարակուած գիտական յօդուած
@hyw
1999 թվականին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mortality and morbidity attributable to use of addictive substances in the United States
@ast
Mortality and morbidity attributable to use of addictive substances in the United States
@en
Mortality and morbidity attributable to use of addictive substances in the United States
@nl
type
label
Mortality and morbidity attributable to use of addictive substances in the United States
@ast
Mortality and morbidity attributable to use of addictive substances in the United States
@en
Mortality and morbidity attributable to use of addictive substances in the United States
@nl
prefLabel
Mortality and morbidity attributable to use of addictive substances in the United States
@ast
Mortality and morbidity attributable to use of addictive substances in the United States
@en
Mortality and morbidity attributable to use of addictive substances in the United States
@nl
P2860
P1476
Mortality and morbidity attributable to use of addictive substances in the United States
@en
P2093
J M McGinnis
P2860
P304
P356
10.1046/J.1525-1381.1999.09256.X
P407
P577
1999-01-01T00:00:00Z